Your session is about to expire
What is Akne-Mycin
ErythromycinThe Generic name of this drug
Treatment SummaryErythromycin is an antibiotic drug used to treat bacterial infections. It was first discovered in 1952 and belongs to the macrolide family of antibiotics, which also includes Azithromycin, Clarithromycin and Spiramycin. Erythromycin can be administered in different forms, such as intravenous, topical and eye drop preparations. It is used to treat infections caused by gram-positive and gram-negative bacteria.
Erythrocin Stearateis the brand name
Akne-Mycin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erythrocin Stearate
Erythromycin
1964
261
Approved as Treatment by the FDA
Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 52 uses which include Bacterial Infections and Upper Respiratory Tract Infection .Bacterial Infections
Upper Respiratory Tract Infection
Listeria monocytogenes infection
prophylaxis of Postoperative Infections
Acne Vulgaris
Used to treat Acne Vulgaris in combination with Tretinoin
predominant skin comedones, papules and pustules
Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin
Conjunctivitis
Staphylococcal Skin Infections
Urethritis
Intestinal amebiasis caused by entamoeba histolytica
Acute Otitis Media caused by Haemophilus Influenzae
Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole
Syphilis
Respiratory Tract Infections
Sulfonamides
Streptococcus pyogenes
Rheumatic Fever
Communicable Diseases
patients with intolerance or contraindications to tetracycline use
uncomplicated endocervical infection
uncomplicated urethral infection
Urinary Tract Infection (UTI)
Lower Respiratory Tract Infection (LRTI)
Diphtheria
Haemophilus Influenzae Infections
Used to treat Haemophilus Influenzae Infections in combination with null
Urethritis
urogenital infections during pregnancy
Ureaplasma urealyticum
Communicable Diseases
pustular lesions
Used to treat pustular lesions in combination with Avobenzone
pneumonia of infancy
Listeriosis
penicillins
Whooping Cough
inflammatory papular lesions
Used to treat inflammatory papular lesions in combination with Avobenzone
Chlamydia Trachomatis
Communicable Diseases
treponema pallidum infection
Primary Syphilis
First episode of rheumatic fever
Pertussis
Mycoplasma pneumoniae infection
Communicable Diseases
diphtheria antitoxin
Staphylococcus (S.) Aureus Infection
Corynebacterium Infections
penicillins
Postoperative Infections
Erythrasma
Corynebacterium minutissimum infection
Rheumatic Fever
Pneumococcal Infections
Legionella pneumophila
Effectiveness
How Akne-Mycin Affects PatientsMacrolides like erythromycin are antibiotics that stop bacterial growth by blocking their ability to make proteins. This drug is effective in treating a range of bacterial infections, however it is important to run tests to see if the bacteria is resistant before administering the antibiotic. Many strains of Haemophilus influenzae are resistant to erythromycin alone, but can be treated with a combination of erythromycin and sulfonamides. Staphylococci may also become resistant to erythromycin during treatment. Erythromycin may also cause diarrhea, liver problems, jaundice,
How Akne-Mycin works in the bodyErythromycin is an antibiotic that works by blocking bacteria from making proteins. It does this by attaching to the ribosomes, which are the parts of bacteria responsible for protein synthesis. This prevents the bacteria from growing and reproducing, leading to the control of various bacterial infections. Erythromycin is a type of macrolide, which has a strong affinity for bacterial ribosomes, making it effective against a wide range of bacteria.
When to interrupt dosage
The advocated dosage of Akne-Mycin hinges upon the specified ailment, such as Chlamydia Trachomatis, penicillins and Syphilis. The amount also pivots on the method of delivery (e.g. Granule, for suspension or Tablet, film coated - Oral) indicated in the following table.Condition
Dosage
Administration
Erythrasma
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Whooping Cough
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Lymphogranuloma Venereum
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Syphilis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Urethritis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Pertussis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
mild Acne vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Endophthalmitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Listeriosis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Intestinal amebiasis caused by entamoeba histolytica
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Acne
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Bacterial Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Ophthalmia neonatorum (gonococcal)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
superficial ocular infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Respiratory Tract Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Urethritis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Rheumatic Fever
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Communicable Diseases
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Communicable Diseases
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Urinary Tract Infection (UTI)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Warnings
Akne-Mycin ContraindicationsCondition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Erythromycin may interact with Pulse Frequency
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Common Akne-Mycin Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be increased when it is combined with Erythromycin.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Erythromycin.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Erythromycin.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Erythromycin.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Erythromycin.
Akne-Mycin Toxicity & Overdose RiskThe toxic dose of erythromycin in rats is 9272mg/kg. If someone has overdosed on erythromycin, they may experience symptoms such as diarrhea, nausea, stomach cramps, and vomiting. Treatment for an erythromycin overdose involves stopping the drug and trying to remove any unabsorbed drug. Patients may also need supportive measures and dialysis may not be able to remove all traces of erythromycin from the body.
Akne-Mycin Novel Uses: Which Conditions Have a Clinical Trial Featuring Akne-Mycin?
53 active trials are currently being conducted to assess the potential of Akne-Mycin to treat Streptococcus pyogenes, Treponema pallidum infection and Rheumatic Fever.Condition
Clinical Trials
Trial Phases
Urethritis
0 Actively Recruiting
Whooping Cough
1 Actively Recruiting
Phase 1
Chancroid
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
Lower Respiratory Tract Infection (LRTI)
1 Actively Recruiting
Phase 3
Sulfonamides
0 Actively Recruiting
Upper Respiratory Tract Infection
3 Actively Recruiting
Not Applicable, Phase 4
First episode of rheumatic fever
0 Actively Recruiting
Corynebacterium minutissimum infection
0 Actively Recruiting
Erythrasma
0 Actively Recruiting
Rheumatic Fever
0 Actively Recruiting
Haemophilus Influenzae Infections
0 Actively Recruiting
Corynebacterium Infections
0 Actively Recruiting
Listeriosis
0 Actively Recruiting
urogenital infections during pregnancy
0 Actively Recruiting
predominant skin comedones, papules and pustules
0 Actively Recruiting
Community Acquired Pneumonia (CAP)
1 Actively Recruiting
Not Applicable
Communicable Diseases
0 Actively Recruiting
inflammatory papular lesions
0 Actively Recruiting
Acne
6 Actively Recruiting
Phase 4, Early Phase 1, Not Applicable, Phase 1, Phase 2
Akne-Mycin Reviews: What are patients saying about Akne-Mycin?
4Patient Review
2/15/2008 I started using this treatment when I was 15 and it's been effective for me. I'm still using it now and would recommend it to others.
2.3Patient Review
5/27/2012 I had a severe reaction to this topical drug, including facial swelling and redness. I discontinued use after having to go to the emergency room.
Patient Q&A Section about akne-mycin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What drugs are in the Mycin family?
"Macrolide antibiotics work by reducing the production of proteins that bacteria need to survive. This slows the growth of bacteria or kills them outright. The most common macrolides are drugs ending in "mycin," such as Zithromax (azithromycin), Biaxin (clarithromycin), and Ery-Tab (erythromycin)."
Answered by AI
What is AKNE Mycin used for?
"It works by stopping the growth of bacteria.
This medication helps to clear acne by reducing the number of pimples. Erythromycin is an antibiotic that works by slowing down the growth of bacteria."
Answered by AI
Is Aknemycin good for acne?
"It prevents the formation of blackheads and spots by attacking the bacteria Propionibacterium acnes that is associated with acne. This type of bacteria feeds on the sebum produced by sebaceous glands in the skin."
Answered by AI
What is by-Mycin tablets used for?
"By-Mycin Capsules is an antibiotic that fights bacteria. It can be used to treat infections such as bronchitis, pneumonia, and sinusitis."
Answered by AI